urology gastroenterology endocrinology orthopaedics research & development therapeutic areas our expertise clinical trials pipeline about ferring philosophy our history management locations responsibility csr review working at ferring learning & development vacancies people come first at ferring media press releases press materials media contacts stories global content search legal disclaimer sitemap can you gamify health exploring applications of gamification for children with chronic conditions read more septic shock why we want to make a difference meet the ferring employees committed to helping patients behind the statistics read more people come first at ferring we believe in the power of people and research and go where ideas and research take us . read more believing in the power of research world leader in peptide and peptidomimetic research read more thinking beyond the needs of today read more driven by research and a passion for science ferring is a biopharmaceutical company dedicated to the development of innovative treatments that make a real difference in people s lives all over the world . active in the areas of reproductive health urology gastroenterology endocrinology and orthopaedics we develop medicine on the body s own terms . we believe in the power of people and research and go where ideas and research take us . what we do ferring pharmaceuticals is devoted to identifying developing and marketing innovative products in the fields of reproductive health urology gastroenterology endocrinology and orthopaedics . read more responsibility the ferring philosophy places people at the heart of what we do . we will address the needs and support those on whom we have an impact in the communities where we operate . read more latest news wednesday 31 august 2016 ferring pharmaceuticals and north zealand university hospital mark first milestone in innovative ibd collaborationread more monday 29 august 2016 ferring pharmaceuticals acquires exclusive licensing rights to condoliase from seikagaku corporationread more monday 04 july 2016 ferring announces phase 3 data for investigational human recombinant fsh with individualised dosing regimen at the 32nd annual meeting of eshre read more headquarters ferring international center s.a.ch . de la vergognausaz 50 1162 saint prexswitzerland tel 41 58 301 00 00fax 41 58 301 00 10 contact global locator country albania argentina armenia australia austria azerbaijan b.v. holding belgium bolivia bosnia & herzegovina brazil bulgaria canada chile china china production china r & d colombia costa rica croatia cuba czech republic czech republic production denmark denmark api production denmark ipc dominican republic ecuador el salvador finland france georgia germany germany production greece guatemala hong kong hungary india ipc r & d india m & s india production ireland israel israel btg italy japan kazakhstan korea kosovo kyrgyzstan macedonia malaysia mexico mexico commercial office middle east middle east algeria office middle east egypt office middle east uae office moldavia mongolia montenegro netherlands nicaragua norway panama paraguay peru fertility line peru gastro urology g & o peru oncology philippines poland portugal romania russia serbia singapore slovakia slovenia south africa spain sweden switzerland switzerland development switzerland headquarters taiwan tajikistan thailand trinidad tobago & carib . islands tunisia turkey turkmenistan uk uk production ukraine us latin america office uruguay us fipcus us fpi us fri us production uzbekistan venezuela fertility venezuela gastro & pediatric vietnam hanoi vietnam hcmc home products research & development about ferring responsibility working at ferring this global corporate website provides general information about the global ferring group . for information about ferring or its products in a specific country please select your country in the global locator . ferring the ferring pharmaceuticals logo and other ferring product trade names are trademarks of ferring b.v. save where indicated otherwise . 2016 ferring b.v. contact legal disclaimer site map